10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001638833-17-000036`
Period End Date	20170630
Filing Date	20170809
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	sgry-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 120 Cash Flow Statement 76 Stockholders Equity 14 Comprehensive Income 20

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$29.87M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$31.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$51.60M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.93M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $31,465 and $29,872, respectively	`AccountsReceivableNetCurrent`	$215.29M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $31,465 and $29,872, respectively	`AccountsReceivableNetCurrent`	$220.59M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Inventories	`InventoryNet`	$28.78M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$29.68M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$32.01M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.33M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Acquisition escrow deposit	`EscrowDepositCurrent`	$7.97M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Acquisition escrow deposit	`EscrowDepositCurrent`	$10.87M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$361.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$352.31M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$204.25M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	48.49M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$205.74M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	48.81M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$43.42M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	48.49M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	48.81M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$48.02M	USD	Point-in-time
Goodwill	`Goodwill`	$1.56B	USD	Point-in-time
Goodwill	`Goodwill`	$1.57B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$34.98M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$34.49M	USD	Point-in-time
Restricted invested assets	`RestrictedCashAndInvestmentsNoncurrent`	$315.00K	USD	Point-in-time
Restricted invested assets	`RestrictedCashAndInvestmentsNoncurrent`	$315.00K	USD	Point-in-time
Long-term deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$80.17M	USD	Point-in-time
Long-term deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$83.79M	USD	Point-in-time
Financing escrow asset	`DepositsAssetsNoncurrent`	$370.00M	USD	Point-in-time
Financing escrow asset	`DepositsAssetsNoncurrent`	-	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$15.63M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$16.43M	USD	Point-in-time
Total assets	`Assets`	$2.30B	USD	Point-in-time
Total assets	`Assets`	$2.67B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$49.77M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$48.21M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$27.44M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$29.27M	USD	Point-in-time
Acquisition escrow liability	`EscrowLiabilityCurrent`	$10.87M	USD	Point-in-time
Acquisition escrow liability	`EscrowLiabilityCurrent`	$7.97M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$68.99M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$72.47M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$29.92M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$27.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$186.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$186.00M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$1.41B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$1.80B	USD	Point-in-time
Long-term tax receivable agreement liability	`DeferredTaxLiabilitiesNoncurrent`	$122.35M	USD	Point-in-time
Long-term tax receivable agreement liability	`DeferredTaxLiabilitiesNoncurrent`	$122.35M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$76.27M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$76.10M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$176.25M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$180.52M	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 300,000,000 shares authorized, 48,810,075 shares issued and outstanding at June 30, 2017; 48,488,616 shares issued and outstanding at December 31, 2016	`CommonStockValueOutstanding`	$488.00K	USD	Point-in-time
Common stock, $0.01 par value, 300,000,000 shares authorized, 48,810,075 shares issued and outstanding at June 30, 2017; 48,488,616 shares issued and outstanding at December 31, 2016	`CommonStockValueOutstanding`	$485.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$320.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$324.34M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-318.58M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-311.35M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$6.25M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$9.68M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$315.00M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$309.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$315.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$324.67M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.67B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.30B	USD	Point-in-time

Income Statement 120 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$289.68M	USD	1 Quarter
Revenues	`Revenues`	$556.75M	USD	2 Qtrs
Revenues	`Revenues`	$574.54M	USD	2 Qtrs
Revenues	`Revenues`	$288.35M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$180.68M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$90.02M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$179.91M	USD	2 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$93.79M	USD	1 Quarter
Supplies	`SuppliesExpense`	$74.08M	USD	1 Quarter
Supplies	`SuppliesExpense`	$145.24M	USD	2 Qtrs
Supplies	`SuppliesExpense`	$66.92M	USD	1 Quarter
Supplies	`SuppliesExpense`	$130.58M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$22.58M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$39.96M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$43.70M	USD	2 Qtrs
Professional and medical fees	`ProfessionalFees`	$20.30M	USD	1 Quarter
Lease expense	`OperatingLeasesRentExpenseNet`	$25.51M	USD	2 Qtrs
Lease expense	`OperatingLeasesRentExpenseNet`	$13.07M	USD	1 Quarter
Lease expense	`OperatingLeasesRentExpenseNet`	$27.30M	USD	2 Qtrs
Lease expense	`OperatingLeasesRentExpenseNet`	$13.67M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$16.09M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$32.24M	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$14.77M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$28.84M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$405.56M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$208.85M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$216.45M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$428.40M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$34.20M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$15.02M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.66M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$27.22M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.42M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.27M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.52M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$3.54M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$11.46M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$7.42M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$5.79M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$1.84M	USD	2 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$1.05M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$1.08M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.25M	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.12M	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.60M	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.33M	USD	1 Quarter
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-405.00K	USD	1 Quarter
Gain on litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Gain on litigation settlement	`GainLossRelatedToLitigationSettlement`	$3.79M	USD	1 Quarter
Gain on litigation settlement	`GainLossRelatedToLitigationSettlement`	$3.79M	USD	2 Qtrs
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	$-8.28M	USD	2 Qtrs
Merger transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$4.50M	USD	2 Qtrs
Merger transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$1.32M	USD	1 Quarter
Merger transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$2.90M	USD	1 Quarter
Merger transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$3.24M	USD	2 Qtrs
Electronic health records incentive income	`IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology`	$302.00K	USD	2 Qtrs
Electronic health records incentive income	`IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology`	$161.00K	USD	1 Quarter
Electronic health records incentive income	`IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology`	$95.00K	USD	2 Qtrs
Electronic health records incentive income	`IncentivePaymentsRecognizedforCertainHospitalsandPhysicianPracticesThatDemonstrateMeaningfulUseofCertifiedElectronicHealthRecordTechnology`	$2.00K	USD	1 Quarter
Other expense (income)	`OtherNonrecurringIncomeExpense`	$-2.00K	USD	2 Qtrs
Other expense (income)	`OtherNonrecurringIncomeExpense`	$40.00K	USD	1 Quarter
Other expense (income)	`OtherNonrecurringIncomeExpense`	$97.00K	USD	2 Qtrs
Other expense (income)	`OtherNonrecurringIncomeExpense`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$495.08M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$471.53M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$250.61M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$238.73M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$85.23M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$50.95M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$37.74M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$79.46M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-48.39M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-26.23M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-50.78M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-25.60M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$12.14M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$28.68M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$36.84M	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$24.71M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$4.19M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$512.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.42M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.63M	USD	2 Qtrs
Net income	`ProfitLoss`	$32.65M	USD	2 Qtrs
Net income	`ProfitLoss`	$26.05M	USD	2 Qtrs
Net income	`ProfitLoss`	$11.63M	USD	1 Quarter
Net income	`ProfitLoss`	$22.29M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.10M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$20.17M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$37.72M	USD	2 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$33.27M	USD	2 Qtrs
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$2.12M	USD	1 Quarter
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-5.07M	USD	2 Qtrs
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-7.22M	USD	2 Qtrs
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-4.47M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.11	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.15	USD	2 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.11	USD	2 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.15	USD	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.11M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.15M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.02M	shares	2 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.02M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.02M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.15M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.11M	shares	2 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.13M	shares	1 Quarter
Contingent acquisition expense	`BusinessCombinationContingentAcquisitionExpense`	$1.53M	USD	2 Qtrs
Contingent acquisition expense	`BusinessCombinationContingentAcquisitionExpense`	$1.53M	USD	1 Quarter
Contingent acquisition expense	`BusinessCombinationContingentAcquisitionExpense`	$1.81M	USD	1 Quarter
Contingent acquisition expense	`BusinessCombinationContingentAcquisitionExpense`	$3.85M	USD	2 Qtrs

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$32.65M	USD	2 Qtrs
Net income	`ProfitLoss`	$26.05M	USD	2 Qtrs
Net income	`ProfitLoss`	$11.63M	USD	1 Quarter
Net income	`ProfitLoss`	$22.29M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.42M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.27M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.52M	USD	2 Qtrs
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	$3.35M	USD	2 Qtrs
Amortization of debt issuance costs and discounts	`AmortizationOfFinancingCostsAndDiscounts`	$3.77M	USD	2 Qtrs
Amortization of unfavorable lease liability	`AmortizationofUnfavorableLeaseLiability`	$216.00K	USD	2 Qtrs
Amortization of unfavorable lease liability	`AmortizationofUnfavorableLeaseLiability`	$162.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$2.07M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$1.44M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$502.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$635.00K	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.12M	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.60M	USD	2 Qtrs
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-1.33M	USD	1 Quarter
Loss on disposal or impairment of long-lived assets, net	`GainLossOnDispositionOfAssets1`	$-405.00K	USD	1 Quarter
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	$-8.28M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.89M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.89M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$3.54M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$11.46M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$7.42M	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$5.79M	USD	1 Quarter
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$611.00K	USD	2 Qtrs
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-487.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.90M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.70M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-24.15M	USD	2 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$7.53M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$56.47M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$74.04M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.35M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.10M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$113.02M	USD	2 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$14.16M	USD	2 Qtrs
Proceeds from divestitures	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Proceeds from divestitures	`ProceedsFromDivestitureOfBusinesses`	$70.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-29.20M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-133.37M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$113.36M	USD	2 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$424.35M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$119.78M	USD	2 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$525.42M	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$941.00K	USD	2 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$12.55M	USD	2 Qtrs
Lender financing escrow fee	`PaymentsOfLoanCosts`	$6.59M	USD	2 Qtrs
Lender financing escrow fee	`PaymentsOfLoanCosts`	-	USD	2 Qtrs
Penalty on prepayment of debt	`DebtInstrumentPrepaymentPenaltyAmount`	-	USD	2 Qtrs
Penalty on prepayment of debt	`DebtInstrumentPrepaymentPenaltyAmount`	$4.90M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$36.84M	USD	2 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$32.36M	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$573.00K	USD	2 Qtrs
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-745.00K	USD	2 Qtrs
Financing lease obligation	`FinanceLeasePrincipalPayments`	$579.00K	USD	2 Qtrs
Financing lease obligation	`FinanceLeasePrincipalPayments`	$390.00K	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.56M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-658.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$53.00M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-39.94M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.66M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.33M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$57.03M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$69.70M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$51.60M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$57.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$57.03M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$69.70M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$51.60M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$57.93M	USD	Point-in-time

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.49M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.81M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$315.52M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$324.67M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$18.94M	USD	2 Qtrs
Issuance of restricted stock, net of forfeitures	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.07M	USD	2 Qtrs
Cancellation of restricted shares	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$658.00K	USD	2 Qtrs
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsandDisposalsofInterestsheldbyNonControllingInterestHoldersNet`	$-849.00K	USD	2 Qtrs
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$28.66M	USD	2 Qtrs
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.49M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.81M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$315.52M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$324.67M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$32.65M	USD	2 Qtrs
Net income	`ProfitLoss`	$26.05M	USD	2 Qtrs
Net income	`ProfitLoss`	$11.63M	USD	1 Quarter
Net income	`ProfitLoss`	$22.29M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	2 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$11.63M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$22.29M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$32.65M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$26.05M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$37.72M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$33.27M	USD	2 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$20.17M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.10M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-5.07M	USD	2 Qtrs
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-7.22M	USD	2 Qtrs
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-4.47M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$2.12M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.